Your browser doesn't support javascript.
loading
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Topp, Max S; van Meerten, Tom; Houot, Roch; Minnema, Monique C; Bouabdallah, Krimo; Lugtenburg, Pieternella J; Thieblemont, Catherine; Wermke, Martin; Song, Kevin W; Avivi, Irit; Kuruvilla, John; Dührsen, Ulrich; Zheng, Yan; Vardhanabhuti, Saran; Dong, Jinghui; Bot, Adrian; Rossi, John M; Plaks, Vicki; Sherman, Marika; Kim, Jenny J; Kerber, Anne; Kersten, Marie José.
Affiliation
  • Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • van Meerten T; University Medical Center Groningen, Groningen, The Netherlands.
  • Houot R; On Behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium).
  • Minnema MC; CHU Rennes, University of Rennes, Inserm & EFS, Rennes, France.
  • Bouabdallah K; On Behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium).
  • Lugtenburg PJ; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Thieblemont C; CHU Bordeaux, Service d'Hématologie et Thérapie Cellulaire, Bordeaux, France.
  • Wermke M; On Behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium).
  • Song KW; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Avivi I; Université de Paris, AP-HP, Hôpital Saint Louis, Hemato-Oncology, DMU HI, Research Unit NF-kappaB, Différenciation et Cancer, Paris, France.
  • Kuruvilla J; NCT/UCC Early Clinical Trial Unit, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Dührsen U; The University of British Columbia, Vancouver, Canada.
  • Zheng Y; Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Vardhanabhuti S; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Dong J; University Hospital Essen, Essen, Germany.
  • Bot A; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Rossi JM; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Plaks V; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Sherman M; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Kim JJ; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Kerber A; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Kersten MJ; Kite, A Gilead Company, Santa Monica, CA, USA.
Br J Haematol ; 195(3): 388-398, 2021 11.
Article in En | MEDLINE | ID: mdl-34590303
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Products / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Adrenal Cortex Hormones / Cytokine Release Syndrome / Nervous System Diseases Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Products / Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse / Adrenal Cortex Hormones / Cytokine Release Syndrome / Nervous System Diseases Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2021 Type: Article Affiliation country: Germany